Volumetric brain reductions in adult patients with phenylketonuria and their relationship with blood phenylalanine levels

dc.contributor.author
Pardo, Jèssica
dc.contributor.author
Capdevila Lacasa, Clara
dc.contributor.author
Segura i Fàbregas, Bàrbara
dc.contributor.author
Pané, Adriana
dc.contributor.author
Montserrat, Cristina
dc.contributor.author
Forga Visa, María De Talló
dc.contributor.author
Moreno Lozano, Pedro Juan
dc.contributor.author
Garrabou Tornos, Glòria
dc.contributor.author
Grau Junyent, Josep M. (Josep Maria)
dc.contributor.author
Junqué i Plaja, Carme, 1955-
dc.contributor.author
Consortium PKU.cat
dc.date.issued
2025-06-27T12:02:48Z
dc.date.issued
2025-06-27T12:02:48Z
dc.date.issued
2024-12-01
dc.date.issued
2025-06-27T12:02:48Z
dc.identifier
1866-1947
dc.identifier
https://hdl.handle.net/2445/221831
dc.identifier
749386
dc.identifier
38907189
dc.description.abstract
Background: Continued dietary treatment since early diagnosis through newborn screening programs usually prevents brain-related complications in phenylketonuria (PKU). However, subtle neurocognitive and brain alterations may be observed in some adult patients despite early treatment. Nevertheless, neuropsychological and neuroimaging studies in the field remain scarce. Objectives: This work aimed to determine possible neuropsychological and structural brain alterations in treated adult patients with PKU. Methods: Thirty-five patients with PKU and 22 healthy controls (HC) underwent neuropsychological assessment and T1-weighted magnetic resonance imaging on a 3 T scanner. FreeSurfer (v.7.1) was used to obtain volumetric measures and SPSS (v27.0.1.0) was used to analyze sociodemographic, neuropsychological, volumetric, and clinical data (p < 0.05). Results: Adult patients with PKU showed significantly lower performance than HC in Full Scale IQ (t = 2.67; p = .010) from the WAIS-IV. The PKU group also showed significantly lower volumes than HC in the pallidum (U = 224.000; p = .008), hippocampus (U = 243.000; p = .020), amygdala (U = 200.000; p = .002), and brainstem (t = 3.17; p = .006) as well as in total cerebral white matter volume (U = 175.000; p = .001). Blood phenylalanine (Phe) levels in PKU patients were negatively correlated with the pallidum (r = -0.417; p = .013) and brainstem (r = -0.455, p = .006) volumes. Conclusions: Adult patients with early-treated PKU showed significantly lower global intelligence than HC. Moreover, these patients showed reduced global white matter volume as well as reductions in the volume of several subcortical grey matter structures, which might be related to the existence of underlying neurodevelopmental alterations. Higher blood Phe levels were also negatively correlated with pallidum and brainstem, suggesting a higher vulnerability of these structures to Phe toxicity.
dc.format
10 p.
dc.format
application/pdf
dc.language
eng
dc.publisher
Springer
dc.relation
Reproducció del document publicat a: https://doi.org/10.1186/s11689-024-09553-w
dc.relation
Journal Of Neurodevelopmental Disorders, 2024, vol. 16, num.1
dc.relation
https://doi.org/10.1186/s11689-024-09553-w
dc.rights
cc-by (c) Pardo, J. et al., 2024
dc.rights
http://creativecommons.org/licenses/by/4.0/
dc.rights
info:eu-repo/semantics/openAccess
dc.source
Articles publicats en revistes (Medicina)
dc.subject
Pacients
dc.subject
Neuropsicologia
dc.subject
Cervell
dc.subject
Fenilcetonúria
dc.subject
Patients
dc.subject
Neuropsychology
dc.subject
Brain
dc.subject
Phenylketonuria
dc.title
Volumetric brain reductions in adult patients with phenylketonuria and their relationship with blood phenylalanine levels
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion


Files in this item

FilesSizeFormatView

There are no files associated with this item.